Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-10-15
DOI
10.1002/jcb.27792
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autophagy-independent increase of ATG5 expression in T cells of multiple sclerosis patients
- (2018) Verica Paunovic et al. JOURNAL OF NEUROIMMUNOLOGY
- Evolving concepts in the treatment of relapsing multiple sclerosis
- (2017) Giancarlo Comi et al. LANCET
- Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway
- (2017) Huiqing Hou et al. NEUROCHEMICAL RESEARCH
- Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
- (2017) Fiona M. Menzies et al. NEURON
- Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
- (2016) Tomas Olsson et al. Nature Reviews Neurology
- T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
- (2016) G. Arbore et al. SCIENCE
- Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders
- (2015) Kenneth Maiese BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Microglia-Mediated Inflammation and Neurodegenerative Disease
- (2015) Ling Xu et al. MOLECULAR NEUROBIOLOGY
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Role of autophagy in the pathogenesis of multiple sclerosis
- (2015) Peizhou Liang et al. Neuroscience Bulletin
- mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation
- (2015) Jong-Seok Moon et al. Cell Reports
- Noncanonical autophagy: one small step for LC3, one giant leap for immunity
- (2013) Payal Mehta et al. CURRENT OPINION IN IMMUNOLOGY
- Inflammasomes and host defenses against bacterial infections
- (2013) Gregory I Vladimer et al. CURRENT OPINION IN MICROBIOLOGY
- Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE)
- (2012) Zhenfei Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Sensing and reacting to microbes through the inflammasomes
- (2012) Luigi Franchi et al. NATURE IMMUNOLOGY
- Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition
- (2011) Shinji Saiki et al. Autophagy
- The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
- (2011) P. Menu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors
- (2011) Vojo Deretic CURRENT OPINION IN IMMUNOLOGY
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats
- (2010) L.Y. Hu et al. NEUROSCIENCE
- Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis
- (2009) Mehrdad Alirezaei et al. Autophagy
- Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation
- (2009) Cinzia Dello Russo et al. BIOCHEMICAL PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started